CD8A and colonic neoplasm: Interestingly, it was reported that in human colon cancer, miR-448 could suppress CD8+ T-cell apoptosis and enhance the CD8+ T-cell response by inhibiting indoleamine 2,3-dioxygenase 1 enzyme function [28].